University of Toronto
Department of Laboratory Medicine & Pathobiology
1 King’s College Circle, 6th Floor
Toronto, ON M5S 1A8, Canada
ComACC Accredited: 1968
Affiliated Institutions
Mount Sinai Hospital: Sinai Health, University Health Network
The Hospital for Sick Children (SickKids)
Sunnybrook Health Sciences Centre
St. Michael’s Hospital: Unity Health Toronto
| Program Co-Director | Program Co-Director | Program Admin |
|---|---|---|
| Paul M. Yip, PhD, FCACB, DABCC | Vathany Kulasingam, PhD, FCACB | Paula Nixon |
| Associate Professor | Associate Professor | Program Coordinator |
| paul.yip@utoronto.ca | vathany.kulasingam@uhn.ca | pathology.residency@utoronto.ca |
| (416) 480-6100 | (416) 340-4800 | (416) 978-7535 |
About the Program
The training program in clinical chemistry, established in 1968, is the largest in Canada and accepts 2 candidates each year. Currently, there are 4 fellows in the program (2 first year, 2 second year).
The program is 2 years in duration. Courses taken by candidates include analytical clinical biochemistry (LMP1203H) and laboratory management. Auditing of other courses are used to supplement foundational learning including introduction to medicine (MED100H), Concepts, Patients & Communities (MED120H/130H), computational biostatistics. Teaching methods used include didactic, directed reading, trainee presentations, seminars, case-oriented teaching, and practical exercises.
The first-year hospital rotation is based on general clinical chemistry which provides direction for the learning experience in the analytical and clinical aspects of the profession. Training in the second year includes specialty rotations in pediatrics & toxicology, genetic metabolic laboratory, microbiology, hematology, and molecular diagnostics. More emphasis on clinical decision making and acting laboratory director occurs in the last 6 months of training.
All fellows are required to carry out at least 3 projects in the area of diagnostic test development/evaluation, and participate in rounds and seminars, case presentation and journal club sessions, weekly discussions with faculty, investigation and approval of specialized tests, teaching, and elective periods for specialization.
Program Requirements
To be considered for the program, prospective fellows must have:
- Doctoral or medical degree(s) in chemistry, biochemistry, biology, medicine, pathology, pathobiology or pharmacology from an accredited university.
- Your PhD defense must be completed before the session start date of July 1. You may apply during the final year of your PhD, but any offer of acceptance would be contingent on the successful completion and defense of your thesis prior to the start of the program.
- A minimum of B+ in relevant courses and overall average during graduate studies.
- Good communication skills – written and verbal.
- A Canadian citizen or permanent resident
To Apply
Applications open: October 1 of the prior year in which training is to start. Application Deadline: January 15 of the year in which training is to start. Interviews: typically held in early February. Training begins on July 1.
The application packet must include:
- Letter of intent
- Curriculum vitae
- Contact information for three references
Training Level
| Postdoctoral Training Level |
|---|
| Number of positions available per year: 2 per year |
| Duration of program: 2 years |
| Approximate annual salary or stipend: PGY Scale |
| Source of funding: Ontario Ministry of Health and University of Toronto |
| Current number of trainees: 4 |
| Number of past graduates: 130 |
Faculty
| Khosrow Adeli, PhD, FCACB, DABCC | Pediatric Clinical Chemistry, Reference Intervals |
| Dana Bailey, PhD, FCACB, DABCC | Routine Chemistry, Immunology, Quality Improvement, Harmonization and Standardization, Health Literacy |
| Daniel Beriault, PhD, FCACB | Endocrinology, Lab Utilization, Toxicology |
| Davor Brinc, PhD, FCACB | Routine and Special Chemistry; Outreach Programs |
| Sarah Delaney, PhD, DABCC, FCACB | Toxicology, TDM, Drug Checking |
| Ashley Di Meo, PhD, FCACB | Cardiac Markers, Cardio-oncology, Immunoassay |
| Eleftherios Diamandis, MD, PhD, FRCPC, FRSC | Cancer, Proteomics, Mass Spectrometry |
| Lei Fu, PhD, FCACB, DABCC | Pregnancy, Prenatal Disorders, Pediatric Clinical Chemistry |
| Barry Hoffman, PhD, FCACB | Maternal Serum Screening Program |
| Benjamin Jung, PhD, FCACB | Pharmacology, Pharmacogenetics, TDM, Toxicology |
| Vathany Kulasingam, PhD, FCACB | Mass Spectrometry, Immunology, Autoimmune Diagnostics, Oncology |
| Jessica Miller, PhD, FCACB | Toxicology, Therapeutic Drug Monitoring, Mass Spectrometry |
| Matthew Lafreniere, PhD | Multiple Myeloma, Autoimmunity, Quality Improvement |
| Felix Leung, PhD, FCACB | Routine Chemistry, Point-of-Care Testing, Laboratory Informatics |
| Rajeevan Selvaratnam, PhD, DABCC | STAT and Automated Chemistry, Immunoassays |
| Lusia Sepiashvili, PhD, FCACB, DABCC | Special Chemistry, Immunology, Pediatric Clinical Chemistry |
| Jennifer Taher, PhD, FCACB | Special Chemistry, Quality Improvement, Lipids & Diabetes, Clinical Research |
| Paul Yip, PhD, FCACB, DABCC | Test Utilization, Quality Management, Point-of-Care Testing |
| Libin Yuan, PhD, FCCMG, FACMG | Metabolic Disease, Inborn Errors of Metabolism, Glycosylation Defects |

